Back | Next |
home / stock / dtil / dtil message board
Subject | By | Source | When |
---|---|---|---|
$DTIL The trading | rtrstock | investorshub | 05/24/2023 9:04:26 PM |
$DTIL bears are running | rtrstock | investorshub | 05/24/2023 4:29:01 PM |
MomentumIts now last trade up | NY1972 | investorshub | 05/24/2023 12:36:45 AM |
Long and strong lets hope im right | jondoeuk | investorshub | 05/23/2023 2:30:50 PM |
MomentumIts trading last up | jondoeuk | investorshub | 05/23/2023 6:50:53 AM |
This was presented (CAR-T) https://annualmeeting.asgct.org/abstracts/abstract-de | jondoeuk | investorshub | 05/18/2023 9:34:57 PM |
Two LBAs (at ASGCT) | jondoeuk | investorshub | 05/12/2023 11:23:02 PM |
It could. Another might be the direction the | jondoeuk | investorshub | 05/11/2023 5:31:08 PM |
Here is 1 reason why CSO left. Looks | NY1972 | investorshub | 05/08/2023 11:00:15 PM |
PhDs love stock options from new bios. The | NY1972 | investorshub | 05/03/2023 7:02:02 PM |
Some of the authors have links to Tune | jondoeuk | investorshub | 05/01/2023 8:53:38 PM |
Too many high paid spoiled PhDs. Too much | NY1972 | investorshub | 04/17/2023 12:06:47 AM |
What is the future of the company? | rtrstock | investorshub | 04/15/2023 10:23:53 PM |
He has now taken up the same position | jondoeuk | investorshub | 04/13/2023 9:26:54 PM |
CSO left. Worse significant antigen expression decrease after | NY1972 | investorshub | 04/12/2023 1:32:00 AM |
Could be. Even if not, every time the | jondoeuk | investorshub | 04/11/2023 7:43:29 PM |
It will be delayed in May. CART is | NY1972 | investorshub | 04/06/2023 6:00:34 PM |
The update is now expected in May. | jondoeuk | investorshub | 04/04/2023 8:37:10 PM |
This is recent https://www.nature.com/articles/s41586-023-05787-1 | jondoeuk | investorshub | 03/18/2023 12:23:55 AM |
Have you seen any tumor biopsy studies comparing | NY1972 | investorshub | 03/16/2023 4:26:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Precision BioSciences Inc. Company Name:
DTIL Stock Symbol:
NYSE Market:
Precision BioSciences Inc. Website:
Precision BioSciences, Inc. (Nasdaq: DTIL) (the “Company”), an advanced gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, elimination, and excision, tod...
Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today announced that it will publish f...
Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, elimination, and excision, today announced that its partner ...